Literature DB >> 8381273

Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.

M Del Rosso1, E Anichini, N Pedersen, F Blasi, G Fibbi, M Pucci, M Ruggiero.   

Abstract

We studied non-mitogenic signal transduction in a human cell line of epidermal origin which is induced to chemotaxis following stimulation with human urokinase-type plasminogen activator (u-PA) or with the amino-terminal fragment (ATF) of u-PA A chain, which specifically interacts with the cellular receptor. U-PA and ATF stimulated the formation of diacylglycerol (DAG) independently of inositol lipid and phosphatidylcholine turnover, but concomitantly with de novo synthesis from glucose, thus resembling the DAG neosynthesis activated by insulin. DAG was measured in normal epidermal cells and in cells transfected with the human u-PA receptor (u-PAR) gene and stimulated with u-PA or ATF. Transfected clones showed an increase of cell motility under an ATF gradient in vitro as well as an increase of DAG production. These findings identify a novel mechanism of second messenger formation that conveys chemotactic signals upon stimulation of the u-PAR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381273     DOI: 10.1006/bbrc.1993.1054

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.

Authors:  D A Waltz; L R Natkin; R M Fujita; Y Wei; H A Chapman
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation.

Authors:  R Farias-Eisner; L Vician; A Silver; S Reddy; S A Rabbani; H R Herschman
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

3.  Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.

Authors:  V Stepanova; S Mukhina; E Köhler; T J Resink; P Erne; V A Tkachuk
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

4.  Searching for depolarization-induced genes that modulate synaptic plasticity and neurotrophin-induced genes that mediate neuronal differentiation.

Authors:  H R Herschman; G D Ferguson; J D Feldman; R Farias-Eisner; L Vician
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

5.  Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation.

Authors:  A Poliakov; V Tkachuk; T Ovchinnikova; N Potapenko; S Bagryantsev; V Stepanova
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

6.  Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression.

Authors:  N K Rao; G P Shi; H A Chapman
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.

Authors:  M E Kroon; P Koolwijk; H van Goor; U H Weidle; A Collen; G van der Pluijm; V W van Hinsbergh
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

8.  Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing.

Authors:  François Maquerlot; Stephane Galiacy; Michel Malo; Christophe Guignabert; Daniel A Lawrence; Maria-Pia d'Ortho; Georgia Barlovatz-Meimon
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  SH2B1beta (SH2-Bbeta) enhances expression of a subset of nerve growth factor-regulated genes important for neuronal differentiation including genes encoding urokinase plasminogen activator receptor and matrix metalloproteinase 3/10.

Authors:  Linyi Chen; Travis J Maures; Hui Jin; Jeffrey S Huo; Shafaat A Rabbani; Jessica Schwartz; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2007-10-18

10.  Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.

Authors:  M Resnati; M Guttinger; S Valcamonica; N Sidenius; F Blasi; F Fazioli
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.